ScreenCell is a company that specializes in the oncology therapeutic area. It develops ScreenCell, non-invasive technology for isolating circulating rare cells (CRCs) from blood, and potentially other atypical cells in biological fluids. The ScreenCell devices provide access to phenotypical, genotypical, and functional characterization of circulating tumor cells (CTCs) and circulating tumor microemboli (CTMs).